학술논문
In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein–Barr virus–associated post-transplant lymphoproliferative disorder
Document Type
Article
Author
Thieme, Constantin J.; Schulz, Malissa; Wehler, Patrizia; Anft, Moritz; Amini, Leila; Blàzquez-Navarro, Arturo; Stervbo, Ulrik; Hecht, Jochen; Nienen, Mikalai; Stittrich, Anna-Barbara; Choi, Mira; Zgoura, Panagiota; Viebahn, Richard; Schmueck-Henneresse, Michael; Reinke, Petra; Westhoff, Timm H.; Roch, Toralf; Babel, Nina
Source
In Kidney International December 2022 102(6):1392-1408
Subject
Language
ISSN
0085-2538